Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,246 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care.
Bapsy PP, Sharan B, Kumar C, Das RP, Rangarajan B, Jain M, Suresh Attili VS, Subramanian S, Aggarwal S, Srivastava M, Vaid A. Bapsy PP, et al. Among authors: jain m. Cytotherapy. 2014 Feb;16(2):234-44. doi: 10.1016/j.jcyt.2013.11.013. Cytotherapy. 2014. PMID: 24438902 Clinical Trial.
Paclitaxel injection concentrate for nanodispersion versus nab-paclitaxel in women with metastatic breast cancer: a multicenter, randomized, comparative phase II/III study.
Jain MM, Gupte SU, Patil SG, Pathak AB, Deshmukh CD, Bhatt N, Haritha C, Govind Babu K, Bondarde SA, Digumarti R, Bajpai J, Kumar R, Bakshi AV, Bhattacharya GS, Patil P, Subramanian S, Vaid AK, Desai CJ, Khopade A, Chimote G, Bapsy PP, Bhowmik S. Jain MM, et al. Breast Cancer Res Treat. 2016 Feb;156(1):125-34. doi: 10.1007/s10549-016-3736-9. Epub 2016 Mar 3. Breast Cancer Res Treat. 2016. PMID: 26941199 Free PMC article. Clinical Trial.
Immune modulation by dendritic-cell-based cancer vaccines.
Kumar C, Kohli S, Bapsy PP, Vaid AK, Jain M, Attili VS, Sharan B. Kumar C, et al. Among authors: jain m. J Biosci. 2017 Mar;42(1):161-173. doi: 10.1007/s12038-017-9665-x. J Biosci. 2017. PMID: 28229976 Review.
A phase III study of belagenpumatucel-L, an allogeneic tumour cell vaccine, as maintenance therapy for non-small cell lung cancer.
Giaccone G, Bazhenova LA, Nemunaitis J, Tan M, Juhász E, Ramlau R, van den Heuvel MM, Lal R, Kloecker GH, Eaton KD, Chu Q, Dunlop DJ, Jain M, Garon EB, Davis CS, Carrier E, Moses SC, Shawler DL, Fakhrai H. Giaccone G, et al. Among authors: jain m. Eur J Cancer. 2015 Nov;51(16):2321-9. doi: 10.1016/j.ejca.2015.07.035. Epub 2015 Aug 14. Eur J Cancer. 2015. PMID: 26283035 Clinical Trial.
Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study.
Harrington K, Temam S, Mehanna H, D'Cruz A, Jain M, D'Onofrio I, Manikhas G, Horvath Z, Sun Y, Dietzsch S, Dubinsky P, Holeckova P, El-Hariry I, Franklin N, Biswas-Baldwin N, Legenne P, Wissel P, Netherway T, Farrell J, Ellis C, Wang-Silvanto J, Amonkar M, Ahmed N, Santillana S, Bourhis J. Harrington K, et al. Among authors: jain m. J Clin Oncol. 2015 Dec 10;33(35):4202-9. doi: 10.1200/JCO.2015.61.4370. Epub 2015 Nov 2. J Clin Oncol. 2015. PMID: 26527790 Clinical Trial.
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.
Sinha SD, Biswas G, Bheemareddy BR, Chary S, Thakur P, Jain M, Maksud T, Pawar S, Chatterjee K, Voonna MK, Goel A, Puligundla KC, Lakshmaiah KC, Talluri L, Vattipalli R, Kakkunnath S. Sinha SD, et al. Among authors: jain m. Cancer Inform. 2023 Jun 1;22:11769351231177277. doi: 10.1177/11769351231177277. eCollection 2023. Cancer Inform. 2023. PMID: 37313371 Free PMC article.
4,246 results